7.9
CiteScore
 
3.6
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
ABUNDANCE ESTIMATION IN AN ARID ENVIRONMENT
Case Study
Correspondence
Corrigendum
Editorial
Full Length Article
Invited review
Letter to the Editor
Original Article
Research Article
Retraction notice
REVIEW
Review Article
SHORT COMMUNICATION
Short review
7.2
CiteScore
3.7
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
ABUNDANCE ESTIMATION IN AN ARID ENVIRONMENT
Case Study
Correspondence
Corrigendum
Editorial
Full Length Article
Invited review
Letter to the Editor
Original Article
Research Article
Retraction notice
REVIEW
Review Article
SHORT COMMUNICATION
Short review
View/Download PDF

Translate this page into:

Research Article
2025
:37;
622025
doi:
10.25259/JKSUS_62_2025

Bioengineered synthesis of iron oxide nanoparticles using Morchella conica: Characterization and evaluation of biomedical applications

Department of Botany, Bacha Khan University, 24420, Khyber Pakhtunkhwa, Pakistan, Charsadda, 24420, Pakistan
Department of Botany, Rawalpindi Women University, 6th Road, Satellite Town, Rawalpindi 46300, Rawalpindi, 46300, Pakistan
Department of Biological Sciences, Texas Tech University, 2901 Main Street, Lubbock, 79409, United States
Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Riyadh, 11451, Saudi Arabia

*Corresponding authors E-mail addresses: tabassumyaseen@bkuc.edu.pk (T. Yaseen); rahmali@ttu.edu (R. Ali)

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Abstract

In the current study, iron oxide nanoparticles (IONPs) were synthesized using edible medicinal mushroom Morchella conica extract as a reducing and capping agent. Further, the Morchella conica-mediated IONPs were characterized using scanning electron microscopy (SEM), ultraviolet (UV), Fourier transform infrared (FT-IR), and X-ray diffraction (XRD). The synthesized IONPs were evaluated for antimicrobial activity against different bacterial and fungal strains and showed the highest zone of inhibition (ZIs) against bacterial and fungal strains. The maximum inhibition concentration (MIC) values for three bacterial strains Bacillus subtilis, Escherichia coli, and Klebisella pneumoniae were found to be 47 μg/mL, 94 μg/mL, and 188 μg/mL, respectively, where Klebsiella pneumonia was found to be the most resistant strain. Bacillus subtilis was reported as the least resistant strain. Among the three fungal strains, Aspergillus flavus was found to be the most resistant strain (MIC: 188μg/mL), followed by Candida albicans (MIC: 94 μg/mL), and the most susceptible strain was Mucor racemosus (MIC: 47 μg/mL). The as-prepared IONPs were further evaluated for anticancer potential, revealing an IC50 value of 41.81 μg/mL against HepG2 cancer cell lines, while the Half maximal inhibitory concentration (IC50) value of the cisplatin, used as a positive control, was recorded as 15.3 μg/mL. The antioxidant potential maximum score for IONPs was determined as 98% at 500 μg/mL, and the minimum was found as 20% at 04 μg/mL. The cytotoxic capability against brine shrimps was measured, yielding an IC50 value of 32.65 μg/mL, while vincristine sulphate demonstrated an IC50 value of 4.99 μg/mL. In conclusion, Morchella conica IONPs have shown potential bioactivities. Further, in vitro and in vivo studies are recommended to comprehensively evaluate the therapeutic potential of Morchella conica-mediated IONPs. Advancing this research toward the development of multifunctional nanoparticles (NPs) for targeted drug delivery will be essential to ensure their safety, efficacy, and clinical applicability.

Keywords

Anticancer
Anti-bacterial
Anti-fungal
Antioxidant
Cytotoxicity
Iron oxide nanoparticles
Morchella Conica

1. Introduction

Nanotechnology is a broad field of science, technology, and engineering that deals with the synthesis, characterization, and applications of nanomaterials. Nanotechnology is seeking knowledge from biology, chemistry, material science, physics, etc (Abbasi et al., 2019). The term “Nano” comes from Greek, meaning “very small or dwarf.” Nanoparticles (NPs) are small-sized particles that range from 1-100 nm in size and possess unique and fascinating chemical, physical, optical, magnetic, and electrical properties, such as different shapes, small size, high surface charge, surface effects, and energy (Munir et al., 2019). Different NPs have been synthesized, including iron, zinc, cobalt, silver, nickel, gold, etc., and possess a wide range of applications in different commercial areas, including medicines, cosmetics, agriculture, and the energy sector (Iqbal et al., 2018). There are different ways for NP fabrication, including the biological, chemical, and physical methods. NP synthesis mostly depends on physical and chemical procedures, both of which have important limitations. Complex and costly machinery are required by physical methodology, which runs under limiting conditions of temperature, pressure, and energy sources (Gupta et al., 2023). Toxic solvents and synthetic chemicals are involved usually in chemical synthetic procedures. The chemicals not only increase synthesis costs but also have health and environmental serious issues. To check these issues, the scientific community has focused on safe methods like green synthesis. This methodology is in line with principles of sustainability, contributing a safer, eco-friendly, and economical alternative to conventional methods (Abbasi et al., 2023). Due to unpaired natural diversity, minimal cost, and less energy needs, biological sources like plants, fungi, algae, bacteria, and animals appeared encouraging in the synthesis of NPs (Purohit et al., 2019). Plants and fungal dependent methodologies are gaining attraction as better microbial techniques (Bihal et al., 2023). In comparison, fungi, mainly mushrooms, provide a captivating direction for NP synthesis. Their extracts are good in multiple bioactive compounds i.e., flavonoids, alkaloids, tannins, quinine, glycosides, triterpenoids, saponins, and phenol, that are used as natural reducing, stabilizing, and capping substances during metal NP production (Haq et al., 2022). The effectiveness of the green synthesis relies on numerous factors, including the concentration and composition of the mushroom extract, pH conditions, the kind of metal group, and the precise synthesis protocol hired (Elsakhawy et al., 2022). As interest in environmentally conscious nanotechnology continues to grow, fungal-mediated syntheses, particularly for iron oxide nanoparticles (IONPs), are receiving heightened attention for their biocompatibility and broad application potential (Dikshit et al., 2021). The current study aims to fabricate IONPs using the Morchella Conica aqueous extract. Recent estimates estimate the total number of mushrooms at 140,000-160,000, with 2.2-3.8 million species of fungi found globally, and merely 10% of the area has been surveyed (Zeb et al., 2021). The scientific community studies several fungal species to expand therapies for different activities like antioxidant, antimicrobial, and anticancer potential (Ray et al., 2024). Trichoderma hamatum, Alternaria solani, Alternaria, Aspergillus japonicus, and Penicillium cyclopium were used in earlier studies to fabricate different metal NPs for the antimicrobial activities (Zakariya et al., 2022). The ethno-pharmacology, diversity, morphological, and biological potentials of different mushroom species from District Swabi, Charsadda, Pakistan were explored by Yaseen et al. (2016), Yaseen et al. (2017), and Hayat et al. (2024). Morchella conica belongs to the Ascomycota and usually grows in mountainous areas, chalky soil, grassy forest, and mostly in deciduous trees like Quercus spp (oak), Populus spp, and Nerium spp (Kapooret al., 2023). There are many therapeutic applications in the treatment of arthritis, rheumatism, heart diseases, infertility, and different cancer problems (Thakur et al., 2021; Mahadeva Kumar et al., 2024).The Morchella conica-mediated IONPs were characterized using scanning electron microscopy (SEM), UV, Fourier transform infrared (FT-IR), and X-ray diffraction (XRD). The synthesized IONPs were evaluated for antimicrobial activity against different bacterial and fungal strains.

2. Materials and Methods

2.1 Morchella conica collection and extract preparation

Morchella conica (Morchellaceae) was collected from District Bajaur, Tehsil Salarzai village, Batwar in the spring season (2022-2023). Bajaur District, located in Pakistan’s North West between 34-72” and 34-74” N and 71-50” and 71-54” E longitudes, is the entrance point to all of Ex-Fata and Khyber Pakhtunkhwa (Khan, 2022). The collected and identified mushroom species were properly cleaned with tap water to obtain clear of any surface contaminants. Morchella conica was shade-dried at room temperature for about 3-4 weeks and ground into fine powder (Hameed et al., 2019; Abdelshafy et al., 2022). For the preparation of Morchella conica extract, 30 g powder was carefully added into a 500 mL flask containing 400 mL of distal water along with a magnet and placed on a hotplate at 80°C for 2 h. The extract was cooled and filtered three times using Whatman filter paper to obtain a pure aqueous extract (Iqbal et al., 2020). After that, pH was recorded at room temperature, and finally, the mushroom extract was stored at 4°C for further studies.

2.2 Synthesis of IONPs

To achieve the purpose of iron NPs from the prepared Morchella conica extract, the acetate precursor salt was utilized. The help of biological synthesis of nanoparticles was done by reducing iron salt. 3 grams of iron salt were steadily mixed with 250 mL filtered Morchella conica extract. To create a standardized solution, the solution mixture was continuously heated for 2 h at 80°C. After that, it was centrifuged for 20 min at 6000 rpm. Following centrifugation, the supernatant was disposed of, and the pellet, which was thought to be IONPs, was carefully cleaned three times with distilled water to get rid of any last contaminants. After that, isolated powder NPs were incubated in a hot air incubator at ∼100°C until the water evaporated completely. The synthesized IONPs were annealed at 400°C to obtain pure crystalline NPs. IONPs were then comprehensively characterized utilizing a variety of characterization methods after the collected powder samples were stored in dry, cold, and dark conditions in airtight vials (15 mL falcon tubes) (Iqbal et al., 2019; Abbasi et al., 2023).

2.3 Characterization of IONPs

The biogenic IONPs were characterized using different characterization techniques. The absorption spectra were measured for determining the bio-reduction of iron ions to IONPs via a UV-4000 UV-Vis spectrophotometer (Lambda 35® PerkinElmer, USA) within the ranges of 200-700 nm (Chatterjee et al., 2020). The elemental composition and morphological study of IONPs were done using SEM (NOVA FEISHM-450), and the FT-IR (Alpha, Bruker, Germany) investigation was achieved from 1000-4000 cm-1, finding out diverse functional groups that control the reduction and effective stabilization of IONPs. The crystal structure of the biogenic IONPs was found out by using analytical XRD (Netherlands), and after that, the crystal size was deliberate by the help of XRD (Abbasi et al., 2019).

2.4 Antibacterial activity

Using the disc diffusion method, the antibacterial activity of IONPs was evaluated against three bacterial strains: Klebsiella pneumoniae (ATCC 4617), Bacillus subtilis (ATCC 6633), and Escherichia coli (ATCC 15224). Nutrient agar plates were equally covered with a 0.1 mL bacterial suspension that had been standardized to 1.0 McFarland turbidity. In accordance with the method outlined by Ansari et al. (2017), sterile 6 mm discs were impregnated with varying concentrations of IONPs (ranging from 47 μg/mL to 1500 μg/mL) and subsequently placed on the inoculated agar surfaces. To assess the antibacterial activity of the produced IONPs, the plates were incubated for 24 h at 37°C. After this, the inhibitory potential zones were assessed in millimeters. The assessments were carried out in a triplicate manner. Amp-B (10μg) was taken as a positive control, and maximum inhibition concentration (MIC) standards of Morchella conica-mediated IONPs were calculated by calculating the zone of inhibition (ZI) (Dharmaratne et al., 2018; Iqbal et al., 2019).

2.5 Antioxidant activity of IONPs

The antioxidant activity of the synthesized IONPs was evaluated by means of the DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical scavenging examination, following the procedure drawn by Yap et al. (2021). Numerous concentrations of IONPs (ranging from 4 to 500 μg/mL) were developed by using distilled water. For each test, 1 mL of the IONP suspension was mixed with 1 mL of fresh prepared DPPH (0.1 mM) solution. The mixtures were vortexed slightly and put to incubate in the dark for 32 min to stop photodegradation. Using Shimadzu UV-Visible spectrophotometer, absorbance readings were recorded at 517 nm. Accuracy was ensured by performing experiments in triplicate. A solution comprising only DPPH was used as the negative control sample, while ascorbic acid was employed as the positive reference standard material. The percentage (%) of DPPH radical scavenging was calculated accordingly (Sridhar and Charles, 2019; Ray et al., 2024).

Absorbance-Absorbance= [ Sample/standard ]   [Absorbance of control] ×  100

2.6 Anticancer activity

To evaluate the anticancer potential of synthesized IONPs, experiments were conducted using the HepG2 human liver cancer cell line. Cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM) enriched with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin to ensure optimal growth conditions. Once a sufficient number of cells were cultured, they were seeded into 96-well microplates and incubated for 24 h at 37°C in a humidified atmosphere containing 5% CO₂ to promote cell attachment. Following the incubation, the cells were exposed to IONPs across a concentration gradient ranging from 3.91 to 500 µg/mL. Cisplatin was used as a reference drug (positive control) for comparative purposes. After treatment, 100 µL of MTT reagent was added to each well, and the plates were incubated for an additional 2 h to allow the formation of formazan crystals by metabolically active cells. Post-incubation, the supernatant was carefully discarded, and 100 µL of DMSO was introduced into each well to dissolve the formed formazan. The optical density, indicative of cell viability was measured at a wavelength of 570 nm using a microplate reader. Finally, the half-maximal inhibitory concentration (IC₅₀) of the IONPs against HepG2 cells was determined based on the absorbance data (Gawel et al., 2022; Zhi et al., 2020).

2.7 Antifungal activity

To find out the antifungal activity of IONPs, the concentration range from 47 up to 1500 µg/mL was selected for the fungal pathogens test. In this study involved three different fungal strains. Aspergillus flavus, Mucor racemosus, (FCBP: 0300) and candida albicans, (FCBP: 478) these three strain were selected to provided a broad representation of pathogenic fungi. The investigational design aimed to find out the fungicidal potential of IONPs by studying their inhibitory effects across diverse dosages. Sabouraud dextrose agar (SDA) was prepared and autoclaved following the manufacture pattern (Ray et al., 2024). Sterile Petri plates were filled with medium (15-20 mL) and left to harden for 15 to 20 min.

Then, 100 mL cotton swabs were used to create identical lawns in Petri dishes using diverse pathogenic fungal strains. Resting on Petri dishes, filter discs with different concentrations of Morchella conica asynthesized IONPs were maintained. Antifungal drug (Amp B) was used as a control. The Petri plates were placed in a 37°C heated incubator for 24 h. The ZIs were measured in millimeters, and the minimum inhibitory concentration (MIC) value was calculated. (Ahmad et al., 2022).

2.8 Cytotoxicity assay against brine shrimps

To study the cytotoxic potential of fabricate IONPs the BSLA was used. The eggs of Artemia salina (Ocean Star, USA) was used for this purpose and was incubated for 24 to 48 H at 30°C under light in seawater (3.8 g/L) for this activity. Using a Pasteur pipette, 10 mature grown phototropic Nauplii were harvested and placed into glass vials filled with IONPs and artificial seawater (Hnamte et al., 2020). IONPs were prepared at various concentrations (ranging 4 to 500 µg/mL) for cytotoxic evaluation. For the positive control, vials include vincristine sulfate, saline solution, and Artemia nauplii (brine shrimp larvae). After a 24-h exposure period, the mortality among the nauplii was recorded in all treatment groups’. The quantity of deceased larvae in each vial was counted, and the data were analyzed using GraphPad software to calculate the median lethal concentration (IC₅₀), as described by Iqbal et al. (2020).

2.9 Statistical analysis

ANOVA was used to compare the groups statistically, and Tukey’s post hoc test was used to find significant differences. A p-value of less than 0.05 was deemed statistically significant.

3. Results & Discussion

In the present study the IONPs were synthesized using a green chemistry, eco-friendly method involving an extract derived from Morchella conica mushroom, which worked as both a reducing and stabilizing agent. Divers analytical techniques were used to explore the mycochemicals properties of the resulting nanoparticles. The synthesized IONPs were initially noticeable and changed color upon the introduction of the precursor salt to the mushroom extract maintained at 80°C (Abbasi et al., 2019; Hassan et al., 2021).

3.1 UV-spectrophotometery

A UV-spectrophotometer was used to confirm the fabrication of IONPs. At a specified wavelength range of 200-800nm, the spectrum was measured. At 302 nm, the broad peak represents maximum absorption. Because of the surface Plasmon resonance (SPR) excitation that caused the color changes and IONP fabrication, the peak was realistic. The range of peaks for IONPs was also reported by Yap et al., 2021. Fig. 1 shows the UV-spectrophotometry for the Morchella conica mediated IONPs. The development of peak is dictated by different factors like shape, size, and polydispersity of IONPs.

UV-Vis spectroscopy for IONPs from Morchella conica.
Fig. 1.
UV-Vis spectroscopy for IONPs from Morchella conica.

3.2 SEM analysis

SEM was used to analyse the surface morphology of the synthesized IONPs, as shown in Fig. 2. The majority of the NPs were spherical, and there was obvious clumping. Electrostatic interactions between the surface layers of the NPs were probably the cause of this clustering behavior. Furthermore, the nhigh surface area-to-volume ratio tends to encourage aggregation in suspension (Jan et al., 2021).

The SEM analysis of Morchella conica-mediated IONPs.
Fig. 2.
The SEM analysis of Morchella conica-mediated IONPs.

3.3 FTIR analysis

FTIR analysis was used to identify the different functional groups responsible for the synthesis of IONPs, as shown in Fig. 3. The IONPs displayed absorption peaks at 357.93, 3290.21, 2842.12, 2202.68, 1726.28, 1022.11, 658.33, and 549.65 cm1, each corresponding to different functional groups. Furthermore, due to their tiny size, NPs have a high surface area-to-volume ratio, which enables them to interact with biological molecules to produce the desired effects. Size and shape play a critical role in defining their functions in biological applications (Hameed et al., 2019).

FT-IR analysis using for functional groups of Morchella conicaIONPs.
Fig. 3.
FT-IR analysis using for functional groups of Morchella conicaIONPs.

3.4 X-ray diffraction analysis

The crystal structure of the biogenic IONPs was determined by using analytical XRD (Netherlands), and after that, the crystal size was calculated (Abbas et al.,2019). The XRD pattern of bio-fabricated IONPs reveals orientation planes at (012), (110), (113), (024), (018), and (214) corresponding to 2θ values of 22.03°, 36.93°, 41.40°, 44.1°, 57.9°, and 62.89°, respectively (Fig. 4). The average size was calculated as 19.78 nm. The absence of Bragg peaks for other related compounds indicates that biogenic IONPs are pure-crystalline. The XRD pattern for IONPs is related to previous results of (Jan et al., 2021; Kapoor et al., 2023).

XRD analysis confirms the crystal size of IONPs.
Fig. 4.
XRD analysis confirms the crystal size of IONPs.

3.5 Anti-bacterial assay

The antibacterial potential of Morchella conica-mediated IONPs has been tested against numerous bacterial strains, including Escherichia coli, Bacillus subtilis, and Klebsiella. Pneumoniae, with concentration ranging from 47 to 1500 μg/mL, by the disc diffusion method, as shown in Fig. 5 and Table 1. The ZIs were measured, and the MIC values were recorded. The most sensitive strain was Bacillus subtilis (47 ±3.1 μg/mL). Escherichia coli and Klebisella pneumoniae were found to be at 94 ± 2.7 μg/mL, and 188 ± 5.2 μg/mL, respectively (n = 3, p < 0.05). One-way ANOVA showed significant differences in MIC values between bacterial and fungal strains. For the positive control, oxytetracycline (10 µg) was used. As compared to the positive control, none of the concentrations showed more potential. The synthesized IONPs have shown potential for antibacterial activity against various bacterial strains (Jan et al., 2021). Different functional groups present on the surface of NPs account for the enhanced antibacterial capability of IONPs. To put it for a short time, IONPs concluded that their response to the various fungal strains was concentration-dependent (Kamal et al., 2023). As the concentration increased, the antibacterial potential also gradually increased. Other researchers have studied the anti-bacterial properties of IONPs, and established that the primary mechanism supplying NPs with anti-bacterial potential and inducing cell death is ROS production (Nayak et al., 2024). Moreover, studies have shown that NPs give the impression of staying on the fungal cell wall’s surface and break it, leading to the denaturation process of membrane protein and ultimately cell death. Similarly, a surface regularity defect in NPs also inhibits bacterial growth and damages cells membranes of microbial cells and also some organelles of the cell (Gupta et al., 2017; Ray et al., 2024). Moreover, several functional groups from the Morchella conica mushroom extract are attached to produce capped IONPs, which are important for inhibiting microbial strains. This study has correlation with (Dharmaratne et al.,2018; Ansari et al., 2017) in term of anti-bacterial potential of IONPs.

Antibacterial potential of as-prepared biogenic IONPs form Morchella conica.
Fig. 5.
Antibacterial potential of as-prepared biogenic IONPs form Morchella conica.
Table 1. MIC values of bacterial and fungal strains.
1 Bacterial strains MICs values (μg/mL)
Gram positive
B. subtilis (ATCC:6633) 47μg/mL
Gram negative
E. coli (ATCC: 15224) 94 μg/mL
K. Pneumonia (ATCC: 4617) 188 μg/mL
2 Fungal strains
C. albicans (FCBP:478) 94 μg/mL
M. racemosus (FCBP:300) 47 μg/mL
A. flavus (FCBP: 0064) 188 μg/mL

3.6 Antifungal activity

To find out the result of IONPs different fungal strains were used to evaluate the fungicidal ability. The three different fungal strains used were Candida albicans (FCBP: 478), Mucor racemosus (FCBP: 0300), and Aspergillus flavus (FCBP: 0064). To find out the antifungal potential of IONPs a range of doses (47–1500 μg/mL) were applied to several fungal strains. Among fungal strains, Aspergillus flavus was the least sensitive (188 ± 4.8μg/mL), followed by Candida albicans (MIC: 94 μg/mL), and the most susceptible fungal strain was Mucor.racemosus (MIC: 47μg/ml) (n = 3). One-way ANOVA showed significant differences in MIC values between bacterial and fungal strains (Ray et al., 2024). Amp-B drug was used as a control, and the ZI was compared with IONPs, and the results have been shown in Fig. 6 and Table 1. Generally, a dose-dependent response was recorded for IONPs. Previous research has reported substantial concentration-mediated fungicidal potencies employing several fungal strains and declared the interaction of IONPs with spores and fungal hyphae, guiding inhibition of their growth (Iqbal et al., 2020; Qadri et al., 2023). These are consistent with our present Morchella conica-IONPs study.

Antifungal potential of as-prepared biogenic IONPs from Morchella conica.
Fig. 6.
Antifungal potential of as-prepared biogenic IONPs from Morchella conica.

3.7 Anticancer activity

Different microbes cause different infections in humans and animals, which are life-threatening. With limited treatment methods available, cancer is globally the leading cause of death. Therefore, there is need for techniques to combat multidrug-resistant bacteria and treat cancer cells using various therapeutic approaches (Catalano et al., 2022). To find out the potential of IONPs, the HepG2 cell line was selected. To quantify the control (cisplatin) and IONP values on fast-growing commercial He-G2 cell lines, a dose range of 3.91-500 μg/mL was applied (Fig. 7). The experimental compound exhibited a dose-dependent inhibition of cell viability. At 500 μg/mL, the cells’ morphology was greatly affected, and after CV staining, the number of attached cells was almost negligible. When the dose was reduced to 7.82 μg/mL, the cell morphology remained rather the same, with only a few stained cells observed. Correlated information was adopted from Gharibkandi et al., 2023 and Manimaran et al., 2024. Anticancer drug (cisplatin) and IONPs were compared with one another. The IC50 value of the cisplatin was 15.32 μg/mL, and IC50 for IONPs was 41.81 μg/mL. Morchella conica-synthesized IONPs showed potential against cancer cell lines. Further decreasing the concentration showed that the number of surviving cells increased, and the cells also started to change their shape from circular to elongated. The drug targeting approach of IONPs for cancer therapy has been exposed by (Zhi et al., 2020; Kamal et al., 2023). IONPs and Cisplatin work by producing reactive oxygen species (ROS), which damage lipids, proteins, and DNA (Sanati et al., 2022). This medication causes intra-strand and inter-strand cross links, which result in strand breakage, by binding to the purine bases of DNA. Additionally, NADPH oxidase (NOX), which is activated by cisplatin converts oxygen into hydrogen peroxide (H2O2) and superoxide radicals (Sulashvili et al., 2024).

Anticancer potential of as-prepared Morchella conica mediated by IONPs.
Fig. 7.
Anticancer potential of as-prepared Morchella conica mediated by IONPs.

3.8 Antioxidant potential of IONPs

The antioxidant potential of IONPs fabricate by using Morchella conica mushroom extracts (Fig. 8). Antioxidant activity was assessed by using different from 4 to 500 μg/mL. the activity showed concentration dependent tendency with the lowest activity observed at 4 μg/mL (approximately 20%) and the highest activity recoded at 500 μg/mL up to 98% (Yap et al., 2021). Mushroom extract plays a dual role in this route by stabilizing and reducing various iron ions during NP fabrication. To clarify the role of reductive compounds contributing to antioxidant performance, DPPH analysis was carried out by (Sousa et al., 2023). The conclusion, the antioxidant competence of the synthesized IONPs diminished with decreasing the concentration of NPs (Nayak et al., 2024). During the process, it was explored that the highest antioxidant capacities correspond to maximum concentration tested, confirming strong DPPH scavenging at 500 μg/mL. The improved stability and reduction competence of the IONPs may be recognized to varied antioxidant constituents obviously present in the Morchella conica mushroom extract. The dissimilarity and differences from previously reported research may be attributed to a number of significant aspects such as experimental conditions, nanoparticle manufacturing, mushrooms used and size of nanoparticles (Sridhar and Charles, 2019; Iqbal et al., 2019; Yap et al., 2021).

Antioxidant potential of asynthesized Morchella conica mediated IONPs.
Fig. 8.
Antioxidant potential of asynthesized Morchella conica mediated IONPs.

3.9 Brine shrimp cytotoxicity assay

The cytotoxicity of as-prepared IONPs was evaluated using the brine shrimp lethality assay (BSLA). For assessing any naturally occurring compound’s biological potential, this test is the most suitable. Green produced IONPs were studied for their cytotoxicity potential utilizing brine shrimps as an experimental organism. Fig. 9 shows the percentage mortalities of biogenic IONPs at different concentration or doses (4-500 μg/mL) (Hnamte et al., 2020). The results indicated a dose-dependent response. As the IONPs concentration increases the cytotoxic capability also increases. The IC50value was measured as 32.65 μg/mL for IONPs. Vincristine sulphate with IC50 value (4.991 μg/mL) was utilized as a positive control. The cytotoxic potential of IONPs was confirmed by these studies. Our test sample was determined to be in the general cytotoxic category. A comparable result was confirmed by Iqbal et al., 2021 and Muhammad et al., 2022.

Cytotoxic potential of Morchella conica asynthesized IONPs against brine shrimps.
Fig. 9.
Cytotoxic potential of Morchella conica asynthesized IONPs against brine shrimps.

4. Conclusion

In this study we concluded that wild mushrooms (Morchella conica) can be used for the successful green production of IONPs. The aqueous extract of the Morchella conica mushroom, which contains great amounts of carbohydrates proteins, polysaccharides, and phenolic compounds, was responsible for the formation, stabilization, and capping of the particles. The functional groups present on the surface of IONPs were verified by FTIR analysis. In the XRD, the sharp and strong diffraction peaks were observed, and the patterns confirm the crystallinity of the myco-synthesized IONPs. The synthesized IONPs were 18.41 nm in size, and the shape was found to be spherical, as verified by the SEM analysis. Synthesized IONPs were effective against different bacterial and fungal strains and have also shown a great role as an anticancer, cytotoxic, and antioxidant agent. It is advised that more research be done to investigate the synthesis mechanisms of IONPs fron medicinal mushrooms, with a special emphasis on Morchella conica. Furthermore, extensive in vitro and in vivo research is required to evaluate the therapeutic potential of IONPs produced using this biological pathway.

Acknowledgments

The authors extend their sincere appreciation to the institutions that supported this research work and to the colleagues whose valuable feedback significantly contributed to its development. The authors would like to extend their sincere appreciation to the Ongoing Research Funding Program, (ORF-2025-350), King Saud University, Riyadh, Saudi Arabia.

CRediT authorship contribution statement

Rehmat Ali, Zahid Ullah, Tabassum Yaseen, Javed Iqbal: Concept, design, literature search, data analysis, manuscript preparation. Kamran Akbar, Farishta Zarshan, Madiha Imtiaz: Literature search, data analysis, manuscript review, Banzeer A. Abbasi: Literature search, data analysis, manuscript editing. Ajaz Ahmad: data analysis, manuscript editing and critical review.

Declaration of competing interest

The authors declare that they have no competing financial interests or personal relationships that could have influenced the work presented in this paper.

Declaration of Generative AI and AI-assisted technologies in the writing process

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

References

  1. , , , , , , , . Bioactivities of Geranium wallichianum leaf extracts conjugated with zinc oxide nanoparticles. Biomolecules. 2019;10:38. https://doi.org/10.3390/biom10010038
    [Google Scholar]
  2. , , , , , . Plant-mediated synthesis of nickel oxide nanoparticles (NiO) via Geranium wallichianum: Characterization and different biological applications. Mater Res Express. 2019;6:0850a7. https://doi.org/10.1088/2053-1591/ab23e1
    [Google Scholar]
  3. , , , , , , . Exploring physical characterization and different bio-applications of Elaeagnusangustifolia orchestrated nickel oxide nanoparticles. Molecules. 2023;28:654. https://doi.org/10.3390/molecules28020654
    [Google Scholar]
  4. , , , , , , . Phenolic compounds from edible mushrooms: Occurrence, biological activity, application and future prospective. Crit Rev Food SciNutr. 2022;62:6204-6224.
    [Google Scholar]
  5. , , , . Antimicrobial activity of actinomycetes extracts against multidrug-resistant Staphylococcus aureus and Salmonella spp. isolated from meat. Alfarama J Basic ApplSci. 2022;3:283-299. https://doi.org/10.21608/ajbas.2022.122842.1090
    [Google Scholar]
  6. , , , , , , . Antibacterial activity of iron oxide nanoparticles synthesized by co-precipitation technology. Pol J ChemTechnol. 2017;19:110-115. https://doi.org/10.1515/pjct-2017-0076
    [Google Scholar]
  7. , , . Magnetic separation of biogenic nanoparticles from aqueous media by unmodified iron oxide nanoparticles. Int J Environ SciTechnol. 2021;18:3883-3894.
    [Google Scholar]
  8. , , , , , , . Entomopathogenic fungi: eco-friendly synthesis of sustainable nanoparticles and their nano pesticide properties. Microorganisms. 2023;11:1617. https://doi.org/10.3390/microorganisms11061617
    [Google Scholar]
  9. , , , , , , , , . Multidrug resistance (MDR): A widespread phenomenon in pharmacological therapies. Molecules. 2022;27:616. https://doi.org/10.3390/molecules27030616
    [Google Scholar]
  10. , , , , . Biofabrication of iron oxide nanoparticles using Aspergillus Niger BSC-1 and removal of Cr(VI) ChemEng J. 2020;385:123790. https://doi.org/10.1016/j.cej.2019.123790
    [Google Scholar]
  11. , , , , , , . Terminalia bellirica fruit extracts: In vitro antibacterial, radical scavenging and cytotoxicity study. BMC Complement Altern Med. 2018;18:1-12. https://doi.org/10.1186/s12906-018-2382-7
    [Google Scholar]
  12. , , , , , , . Green synthesis of metallic nanoparticles: Applications and limitations. Catalysts. 2021;11:902. https://doi.org/10.3390/catal11080902
    [Google Scholar]
  13. , , , , , , . Green synthesis of nanoparticles by mushrooms for sustainable soil management. Sustainability. 2022;14:4328. https://doi.org/10.3390/su14074328
    [Google Scholar]
  14. , , . Metal-based nanostructured therapeutic strategies for glioblastoma. Biomedicines. 2022;10:1598. https://doi.org/10.3390/biomedicines10071598
    [Google Scholar]
  15. , , , , , . Au@109Pd nanoparticles conjugated to trastuzumab for HER2+ cancer therapy. EJNMMI Radiopharm Chem. 2023;8:26. https://doi.org/10.1186/s41181-023-00212-4
    [Google Scholar]
  16. , , , . Green and sustainable synthesis of nanomaterials: Recent advancements and limitations. Environ Res. 2023;231:116316. https://doi.org/10.1016/j.envres.2023.116316
    [Google Scholar]
  17. , , , , , , . Green synthesis of zinc nanoparticles for cancer theragnostic. Mater Res Express. 2019;6:102005.
    [Google Scholar]
  18. , , . Evaluation of the toxicity of nanoparticles using brine shrimp. Model Organisms to Study Biol Activities Toxicity Nanoparticles, 2020:401-415. http://dx.doi.org/10.1007/978-981-15-1702-0_19
    [Google Scholar]
  19. , , , , , , , , , . Ethnobotanical diversity, phytochemical screening and biological evaluation of selected medicinal mushrooms species. J King Saud Univ Sci. 2024;36:103428. https://doi.org/10.1016/j.jksus.2024.103428
    [Google Scholar]
  20. , , , . Antibacterial activity of Morchella conica and M. esculenta extracts against 2022:Salmonella. Int J Med Mushrooms 24. https://doi.org/10.1615/intjmedmushrooms.2022044572
    [Google Scholar]
  21. , , , , , . Green synthesis of ZnONPs: Cytotoxic, antimicrobial and antioxidant evaluation. J MolStruct. 2019;1189:315-327.
    [Google Scholar]
  22. , , , , , . Green synthesis of chromium oxide nanoparticles and biological activity. Microsc Res Tech. 2020;83:706-719.
    [Google Scholar]
  23. , , , , , , . Zinc oxide nanoparticles using elaeagnus angustifolia L. leaf extract. Sci Rep. 2021;11:20988.
    [Google Scholar]
  24. , , , , , , . IoT architecture for energy control in smart homes. Sustain Cities Soc. 2018;43:443-450.
    [Google Scholar]
  25. , , , , , , . Review on biosynthesis and biomedical applications of platinum nanoparticles. J Saudi ChemSoc. 2021;25:101297.
    [Google Scholar]
  26. , , , , , , . Green synthesis of Fe-ZnO nanoparticles using mushroom extract. Catalysts. 2023;13:400.
    [Google Scholar]
  27. , , , , . 189 Morchella esculenta (Gucchi)/morchella conica – Krombh/Morchella elata Fr., Family – Morchellaceae. In: Edible and Medicinal Mushrooms of the Himalayas Edible and Medicinal Mushrooms of the Himalayas. Boca Raton: CRC Press; p. :189-209. https://doi.org/10.1201/9781003259763-10
    [Google Scholar]
  28. . State governance in FATA: Merging tribal Pakhtuns through love, not force. In: Mainstreaming the Tribal Areas. Springer; . p. :287-340.
    [Google Scholar]
  29. , , , , , . Ethnomedicinal uses of 100 wild mushrooms from the Indian Subcontinent. In: Ethnic Knowledge and Perspectives of Medicinal Plants. . p. :545-576.
    [Google Scholar]
  30. , , , , , . Iron oxide nanoparticles from Pleurotus citrinopileatus extract: Biomedical applications. Biomass Convers Biorefinery. 2024;14:12575-12585.
    [Google Scholar]
  31. , , , , , , . Carbon dots-supported Fe nanozyme for glioblastoma therapy. Nano Today. 2022;45:101530. https://doi.org/10.1016/j.nantod.2022.101530
    [Google Scholar]
  32. , , , , . Cancer diagnosis using deep learning: A review. Cancers. 2019;11:1235. https://doi.org/10.3390/cancers11091235
    [Google Scholar]
  33. , , , , , , , , . Eco-friendly mycogenic synthesis of iron oxide nanoparticles using volvariella volvacea and unveiling its potential as antibiofilm and anticancer agents. ECS J Solid State Sci Tech Technol. 2024;13:087003. https://doi.org/10.1149/2162-8777/ad658b
    [Google Scholar]
  34. , , . Microbial nanoparticle synthesis: Approaches and application. In: Microbial Nanobionics. Vol 2. . p. :35-60.
    [Google Scholar]
  35. , , , , . Immunotherapies against bacterial and fungal diseases: A review. Front Med. 2023;10:1135541. https://doi.org/10.3389/fmed.2023.1135541
    [Google Scholar]
  36. , , . Exploring the therapeutic properties of Chinese mushrooms with a focus on their anti-cancer effects: A systematic review. Pharmacological Research-Modern Chin Med 2024:100433. https://doi.org/10.1016/j.prmcm.2024.100433
    [Google Scholar]
  37. , , , , . Trends in nanoparticle cancer therapy: Oxidative stress involvement. J Control Release. 2022;348:287-304. https://doi.org/10.1016/j.jconrel.2022.05.035
    [Google Scholar]
  38. , , . Health-promoting properties of edible mushroom proteins. Curr Pharm Des. 2023;29:804-823. https://doi.org/10.2174/1381612829666221223103756
    [Google Scholar]
  39. , . Antioxidant activity of Kyoho grape extracts using DPPH and ABTS assays. Food Chem. 2019;275:41-49.
    [Google Scholar]
  40. , , , , , , . Modern achievements and adverse effects of cisplatin. ббк 52.8 а. 2024;43:73.
    [Google Scholar]
  41. , , . Ethnomedicinal value of Morchella esculenta in Himachal Pradesh. Curr Res Environ Appl Mycol. 2021;11:284-293.
    [Google Scholar]
  42. , , , , , , . Nanocarriers for natural product drug delivery in breast cancer. Int J Nanomed. 2021;16:7891-7941.
    [Google Scholar]
  43. . Morphological study of edible and non- edible mushrooms, district Swabi, Khyber Pakhtunkhwa, Pakistan. PAB 2016:5. https://doi.org/10.19045/bspab.2016.50112
    [Google Scholar]
  44. , , . Morphological study of some mushroom species distributed in district charsadda, khyber pakhtunkhwa province, Pakistan. Sindh Univ Res Jour (Sci. Ser.). 2017;49:747--752. https://doi.org/10.26692/surj/2017.12.52
    [Google Scholar]
  45. , , . Antioxidant and antibacterial activity of IONPs synthesized from Penicillium spp. Sens Int. 2022;3:100164. http://dx.doi.org/10.1016/j.sintl.2022.100164
    [Google Scholar]
  46. , . Medicinal properties and bioactive compounds from wild North American mushrooms. Molecules. 2021;26:251. https://doi.org/10.3390/molecules26020251
    [Google Scholar]
  47. , , , , . Targeting strategies for SPIONs in cancer therapy. Acta Biomater. 2020;102:13-34. https://doi.org/10.1016/j.actbio.2019.11.027
    [Google Scholar]
Show Sections